A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
IDEAYA Biosciences
IDEAYA Biosciences
Molecular Partners AG
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Tanabe Pharma America, Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phanes Therapeutics
Travera Inc
Turning Point Therapeutics, Inc.
Fudan University